Although the elevation of LGR5 expression and potential association with clinical outcome have been observed in HCC patients, whether it can serve as an independent prognostic biomarker remains to be further investigated in specifically designed tumor marker prognostic studies in patients29. This evidence concerns the gene LGR5 and hepatocellular carcinoma.